What are the treatment options for migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Migraine

For migraine treatment, a combination of a triptan with a nonsteroidal anti-inflammatory drug (NSAID) or acetaminophen is the first-line therapy for moderate to severe attacks, while NSAIDs or acetaminophen alone are recommended for mild attacks. 1

Acute Migraine Treatment

First-Line Options Based on Severity

  • Mild attacks:

    • NSAIDs (aspirin, celecoxib, diclofenac, ibuprofen, naproxen)
    • Acetaminophen
    • Aspirin-acetaminophen-caffeine combination (strongly recommended) 1
  • Moderate to severe attacks:

    • Start with NSAID or acetaminophen
    • Add a triptan if inadequate response
    • Combination therapy is more effective than monotherapy 1

Triptan Selection

  • Options include sumatriptan, almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, or zolmitriptan
  • Clinical trials show sumatriptan is effective with 50-62% of patients achieving headache response within 2 hours and 65-79% within 4 hours 2
  • For patients with nausea/vomiting, consider non-oral triptans (nasal, injectable) with an antiemetic 1

Second-Line Options

  • CGRP antagonists (rimegepant, ubrogepant, zavegepant)
  • Dihydroergotamine
  • Lasmiditan (a ditan) 1

Preventive Treatment for Episodic Migraine

First-Line Preventive Medications

  1. Beta-blockers (metoprolol, propranolol)
  2. Valproate/divalproex sodium
  3. Venlafaxine
  4. Amitriptyline 1

Second-Line Preventive Options

  • CGRP antagonists (atogepant, rimegepant)
  • CGRP monoclonal antibodies (eptinezumab, erenumab, fremanezumab, galcanezumab) 1

Third-Line Preventive Option

  • Topiramate 1

Additional Options (if first-line not tolerated or ineffective)

  • ACE inhibitor (lisinopril)
  • ARBs (candesartan, telmisartan)
  • SSRI (fluoxetine) 3

Non-Pharmacological Approaches

Lifestyle Modifications

  • Identify and avoid migraine triggers
  • Maintain regular sleep, eating, and physical activity habits
  • Stay hydrated 3, 1

Evidence-Based Non-Pharmacological Treatments

  • Cognitive behavioral therapy
  • Relaxation training
  • Mindfulness-based treatment
  • Regular aerobic exercise (as effective as relaxation therapy or topiramate)
  • Oral magnesium (400-600mg daily) 1

Important Clinical Considerations

Timing of Treatment

  • Begin treatment as early as possible after migraine onset
  • Early intervention improves efficacy 1

Medication Overuse Warning

  • Monitor for medication overuse headache (≥15 days/month for ≥3 months)
  • Risk thresholds: ≥15 days/month with NSAIDs, ≥10 days/month with triptans 1

Contraindications

  • Triptans: contraindicated in cerebrovascular disease, coronary artery disease, uncontrolled hypertension, or hemiplegic migraine 1, 2
  • NSAIDs: use with caution in GI, renal, or cardiovascular disease 1
  • Women with migraine with aura: combined hormonal contraceptives with estrogens are contraindicated due to increased stroke risk 1

Dosing Considerations

  • Start preventive medications at a low dose and gradually increase until desired outcomes are achieved 3
  • Consider a 2-3 month trial period before switching preventive medications 3

Monitoring

  • Use a headache diary to track frequency, severity, medication use, and response to treatment 3, 1
  • Regularly reevaluate the need for continued preventive treatment 3

Special Populations

Women of Childbearing Potential

  • Discuss adverse effects of medications during pregnancy and lactation 3
  • Women with migraine with aura have significantly higher risk of ischemic stroke (RR 2.08) 1

Patients with Frequent Attacks

  • Consider preventive therapy for patients with severe debilitating headaches despite adequate acute treatment 3
  • Consider preventive therapy for patients unable to tolerate acute treatments or using them more often than recommended 3

By following this treatment approach and considering individual patient factors, most migraine patients can achieve significant improvement in their condition.

References

Guideline

Acute Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.